TOP TIERMARKET NEWSWIRE

News & sentiment

STRUCTURE THERAPEUTI ADR (GPCR) — News & AI sentiment

STRUCTURE THERAPEUTI ADR (GPCR) news roundup. 13 stories in the past week, 20 over 30 days. Average 30-day sentiment is 58.6/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

13

avg sentiment 58.2/100

30d stories

20

avg sentiment 58.6/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

GPCR news in the last 24 hours, 7 days, 30 days and 90 days

How much GPCR coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	GPCR stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	13	58.2/100	GPCR headlines →
Last 30 days	20	58.6/100	GPCR headlines →
Last 90 days	32	55.8/100	GPCR headlines →

Latest stories on GPCR

Structure Therapeutics Inc. (GPCR) Discusses Positive Clinical Data Updates for Oral Small Molecule Amylin and GLP-1 Programs in Chronic Weight Management - Slideshow

Seeking Alpha67 · bullishproduct/pr

4d ago

Structure Therapeutics: The Amylin Data Changes The Math

Seeking Alpha67 · bullishproduct/pr

4d ago

Citizens reiterates Structure Therapeutics stock rating on trial data

Investing.com Analyst Ratings56 · neutralanalyst

4d ago

Structure Therapeutics Inc. (GPCR) Discusses Positive Clinical Data Updates for Oral Small Molecule Amylin and GLP-1 Programs in Chronic Weight Management Transcript

Seeking Alpha67 · bullishproduct/pr

5d ago

Structure weakness ‘disconnected’ from underlying data, says Jefferies

The Fly38 · neutralanalyst

5d ago

Structure obesity portfolio updates ‘encouraging,’ says Clear Street

The Fly56 · neutralgeneral

5d ago

Structure Therapeutics falls after trial data for lead obesity drugs

Seeking Alpha34 · bearishearnings

5d ago

Jefferies raises Structure Therapeutics stock target on amylin data

Investing.com Analyst Ratings61 · neutralanalyst

5d ago

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

The Fly59 · neutralproduct/pr

5d ago

Structure Therapeutics Reports Positive ACCG-2671 Early Trial Results

TipRanks67 · bullishproduct/pr

5d ago

Structure Therapeutics Inc. (GPCR) files 8-K

SEC 8-K50 · neutralgeneral

5d ago

Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management

Business Insider67 · bullishproduct/pr

5d ago

Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management

GlobeNewswire67 · bullishproduct/pr

5d ago

Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences

GlobeNewswire56 · neutralgeneral

Sep 3

Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences

Business Insider56 · neutralgeneral

Sep 3

RNAV8 Bio Joins Team Selected for ARPA-H Funding to Develop Programmable RNA Medicines

PR Newswire67 · bullishproduct/pr

Sep 1

Structure Research Releases 2026 Global Colocation Report and Free Market Tiering Report Covering 101 Data Centre Markets

Business Insider50 · neutralgeneral

Aug 26

Structure Research Releases 2026 Global Colocation Report and Free Market Tiering Report Covering 101 Data Centre Markets

GlobeNewswire55 · neutralproduct/pr

Aug 26

Nancy Pelosi Made Millions On Nvidia Options. Now She’s Betting $3 Million On 1 AI Energy Stock

Yahoo Finance58 · neutralgeneral

Aug 25

Structure Therapeutics: A Strong Bet For An Oral GLP-1 Approval Before 2030

Seeking Alpha73 · bullishproduct/pr

Aug 21

Citizens lowers Structure Therapeutics stock price target on GLP agonist

Investing.com Analyst Ratings34 · bearishanalyst

Aug 7

Structure Therapeutics Price Target Raised To 111 From 101 At Canaccord

The Fly61 · neutralanalyst

Aug 7

Structure Therapeutics Price Target Lowered To 97 From 100 At Citi

The Fly34 · bearishanalyst

Aug 7

Structure Therapeutics price target lowered to $110 from $113 at Citizens

The Fly38 · neutralanalyst

Aug 7

Structure Therapeutics Inc. (GPCR) files 8-K

SEC 8-K50 · neutralgeneral

Aug 6

Open GPCR in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →